Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301157 · ClinicalTrials.gov registry record · Phase 2
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
A Phase 2 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 294
- Enrollment target
NCT01301157 is a Phase 2 study that has completed, run by Maruho Co.. The registered enrollment target is 294 participants.
The verdict
NCT01301157, a Phase 2 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 294 participants
- Enrollment target
Study Summary
This study is to evaluate the efficacy and safety of M518101 and the dose relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients.
Interventions
- DRUG placebo
- DRUG M518101
- DRUG Dovonex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2011-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01301157
The ClinicalTrials.gov registry entry for NCT01301157 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maruho Co., which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01301157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01301157 about?
NCT01301157 is a clinical study titled "Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients". This study is to evaluate the efficacy and safety of M518101 and the dose relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients.
What is the current status of trial NCT01301157?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 294 participants. The study started on 2011-02.
What interventions are being tested in trial NCT01301157?
The interventions under investigation include: placebo (DRUG), M518101 (DRUG), Dovonex (DRUG).
Who is sponsoring clinical trial NCT01301157?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.